Dose-dependent effect of mammographic breast density on the risk of contralateral breast cancer

A model for individualized risk prediction of contralateral breast cancer

(2016) Marzana Chowdhury et al.   BREAST CANCER RESEARCH AND TREATMENT

Perceptions of Contralateral Breast Cancer Risk: A Prospective, Longitudinal Study

(2015) Pamela R. Portschy et al.   ANNALS OF SURGICAL ONCOLOGY

The Manchester guidelines for contralateral risk-reducing mastectomy

(2015) Narendra Nath Basu et al.   World Journal of Surgical Oncology

Contralateral risk-reducing mastectomy in sporadic breast cancer

(2013) John A Murphy et al.   LANCET ONCOLOGY

Perceptions of Contralateral Breast Cancer: An Overestimation of Risk

(2011) Andrea Abbott et al.   ANNALS OF SURGICAL ONCOLOGY

Contralateral Prophylactic Mastectomy: What Do We Know and What Do Our Patients Know?

(2011) Seema A. Khan   JOURNAL OF CLINICAL ONCOLOGY

Clinical Management Factors Contribute to the Decision for Contralateral Prophylactic Mastectomy

(2011) Tari A. King et al.   JOURNAL OF CLINICAL ONCOLOGY

Declining Incidence of Contralateral Breast Cancer in the United States From 1975 to 2006

(2011) Hazel B. Nichols et al.   JOURNAL OF CLINICAL ONCOLOGY

Current Knowledge on Contralateral Prophylactic Mastectomy Among Women with Sporadic Breast Cancer

(2011) A. M. Brewster et al.   ONCOLOGIST

Trends in Contralateral Prophylactic Mastectomy for Unilateral Cancer: A Report From the National Cancer Data Base, 1998–2007

(2010) Katharine Yao et al.   ANNALS OF SURGICAL ONCOLOGY

Risk of second breast cancer according to estrogen receptor status and family history

(2010) Christine Bouchardy et al.   BREAST CANCER RESEARCH AND TREATMENT

Mammographic Density and Risk of Second Breast Cancer after Ductal Carcinoma In situ

(2010) L. A. Habel et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Breast Tissue Composition and Susceptibility to Breast Cancer

(2010) N. F. Boyd et al.   JNCI-Journal of the National Cancer Institute

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial

(2010) Jack Cuzick et al.   LANCET ONCOLOGY

Increasing Rates of Contralateral Prophylactic Mastectomy Among Patients With Ductal Carcinoma In Situ

(2009) Todd M. Tuttle et al.   JOURNAL OF CLINICAL ONCOLOGY

Trends in Mastectomy Rates at the Mayo Clinic Rochester: Effect of Surgical Year and Preoperative Magnetic Resonance Imaging

(2009) Rajini Katipamula et al.   JOURNAL OF CLINICAL ONCOLOGY

Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

(2009) Monika K. Graeser et al.   JOURNAL OF CLINICAL ONCOLOGY

Second Primary Breast Cancer Occurrence According to Hormone Receptor Status

(2009) A. W. Kurian et al.   JNCI-Journal of the National Cancer Institute

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial

(2008)   LANCET ONCOLOGY

Effect of Systemic Adjuvant Treatment on Risk for Contralateral Breast Cancer in the Women's Environment, Cancer and Radiation Epidemiology Study

(2007) Lisbeth Bertelsen et al.   JNCI-Journal of the National Cancer Institute